| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 7.672 | 284.499 | 6.560 | 182.813 | 521.972 | 974.514 | 624.424 | 124.788 | 56.243 |
| Total Income - EUR | - | 7.827 | 284.713 | 6.560 | 182.818 | 522.040 | 974.528 | 627.089 | 134.860 | 59.228 |
| Total Expenses - EUR | - | 7.831 | 289.379 | 1.400 | 175.579 | 448.712 | 926.123 | 632.415 | 236.921 | 295.730 |
| Gross Profit/Loss - EUR | - | -4 | -4.666 | 5.160 | 7.239 | 73.329 | 48.404 | -5.326 | -102.061 | -236.502 |
| Net Profit/Loss - EUR | - | -173 | -12.230 | 4.964 | 5.268 | 68.105 | 38.659 | -11.597 | -102.912 | -236.502 |
| Employees | - | 1 | 1 | 1 | 2 | 3 | 6 | 5 | 2 | 1 |
Check the financial reports for the company - Versus Pharma Supplier S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 83 | 50 | 18 | 0 | 4.940 | 9.883 | 14.700 | 71.567 | 59.495 |
| Current Assets | - | 3.252 | 4.085 | 6.514 | 21.579 | 230.042 | 88.377 | 203.052 | 220.771 | 276.335 |
| Inventories | - | 0 | 0 | 0 | 0 | 1.524 | 2.566 | 48.104 | 73.675 | 2.552 |
| Receivables | - | 834 | 813 | 582 | 2.619 | 211.258 | 66.315 | 147.678 | 142.208 | 267.004 |
| Cash | - | 2.418 | 3.272 | 5.932 | 18.960 | 17.260 | 19.496 | 7.270 | 4.888 | 6.779 |
| Shareholders Funds | - | -128 | -12.356 | -7.165 | -957 | 81.739 | 53.879 | 43.260 | -59.783 | -295.952 |
| Social Capital | - | 45 | 44 | 43 | 843 | 827 | 809 | 1.622 | 1.617 | 1.608 |
| Debts | - | 3.463 | 16.491 | 13.697 | 13.780 | 153.242 | 44.380 | 175.233 | 762.021 | 1.039.390 |
| Income in Advance | - | 0 | 0 | 0 | 8.756 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Versus Pharma Supplier S.r.l.